Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by application of an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.

Disclosed herein is a medical instrument (100, 200, 300, 400, 500, 600, 900) comprising a subject support (102) configured for supporting a subject (110) in a Fowler's position during a magnetic resonance imaging examination. The subject support comprises a leg support region (104) configured for supporting a leg region of the subject horizontally. The subject support further comprises a thoracic support (106) configured for supporting an upper body region of the subject. The subject support is configured such that the thoracic support is inclined (108) with respect to the leg support region to hold the subject in the Fowler's position. The medical instrument further comprises a breast support (114). The breast support comprises a planar support surface (116) configured for supporting breasts of the subject. The breast support is connected to the subject support. The support surface is configured for being horizontal during the magnetic resonance imaging examination.

Disclosed herein is a method of characterising physical properties of an attenuating element in a radiotherapy device having a radiotherapy radiation source and a radiotherapy radiation detector on respective sides of the attenuating element. The method comprises obtaining an average detected radiotherapy radiation intensity at two or more locations around the attenuating element, comparing the detected intensity at one location with the average intensity, and characterising a corresponding physical property based on the comparison.

A radiotherapy system (220, 320) comprises a first rotary support apparatus (204, 304) configured to support a radiation beam source (200, 300) and to cause a radiation beam source (200, 300) to rotate about a rotation axis (218, 318, 518), a second rotary support apparatus (214, 314, 414, 514) and a radiation shield (202, 302, 402, 502) mounted to the second rotary support apparatus (214, 314, 414, 514). The second rotary support apparatus (214, 314, 414, 514) is configured to cause the radiation shield (202, 302, 402, 502) to rotate about the rotation axis (218, 318, 518).

The present disclosure provides methods of treating cancer in a patient comprising administering a combination of a low dose radiotherapy and an immune checkpoint inhibitor therapy. The patient may be further administered a cell therapy, such as chimeric antigen receptor T-cell therapy or chimeric antigen receptor NK-cell therapy. The low dose radiation modulates the tumor microenvironment of solid tumors to allow better efficacy, activation, and infiltration of the anti-tumor effector immune cells.

The present disclosure provides methods of treating cancer in a patient comprising administering a combination of a low dose radiotherapy and an immune checkpoint inhibitor therapy. The patient may be further administered a cell therapy, such as chimeric antigen receptor T-cell therapy or chimeric antigen receptor NK-cell therapy. The low dose radiation modulates the tumor microenvironment of solid tumors to allow better efficacy, activation, and infiltration of the anti-tumor effector immune cells.

A treatment device includes a pulsed particles accelerator and a processor for controlling the latter to deliver a treatment plan by deposition at HDR of charged particles into a flash volume (Vht) by PBS. To shorten the time for depositing a target dose (Dti) into the cells spanned by the flash spots (Si) of the flash volume (Vht), the flash spots are combined into k sets of n flash spots (Si). After depositing a j.sup.th pulse dose (Dij) into the cells spanned by a i.sup.th flash spot (Si) the beam commutes from the ith flash spot (Si) to a next (i+1)th flash spot according to a flash scanning subsequence to deposit a jth dose into the cells spanned by each of the subsequent flash spots of the flash scanning subsequence, until returning to the ith flash spot to deposit a (j+1)th dose (Di(j+1)), and so on When all the cells spanned by all the flash spots of a set have received their corresponding target dose, the beam moves to a next set of combined flash spots and repeats the foregoing pulse deposition steps.

A treatment device includes a pulsed particles accelerator and a processor for controlling the latter to deliver a treatment plan by deposition at HDR of charged particles into a flash volume (Vht) by PBS. To shorten the time for depositing a target dose (Dti) into the cells spanned by the flash spots (Si) of the flash volume (Vht), the flash spots are combined into k sets of n flash spots (Si). After depositing a j.sup.th pulse dose (Dij) into the cells spanned by a i.sup.th flash spot (Si) the beam commutes from the ith flash spot (Si) to a next (i+1)th flash spot according to a flash scanning subsequence to deposit a jth dose into the cells spanned by each of the subsequent flash spots of the flash scanning subsequence, until returning to the ith flash spot to deposit a (j+1)th dose (Di(j+1)), and so on When all the cells spanned by all the flash spots of a set have received their corresponding target dose, the beam moves to a next set of combined flash spots and repeats the foregoing pulse deposition steps.

A microparticle for drug loading, a drug loading microparticle, a particle containing tube, and an implantation system for the microparticle. The microparticle for drug loading includes a housing (31) and a drug loading part (34) located inside the housing and is used for being implanted into body tissues by means of a puncture needle (5); the housing (31) is provided with at least one micro-hole (33) running through the wall thickness of the housing (31); and the drug loading part (34) is located inside the housing (31) and is used for loading drugs. The microparticle for drug loading/drug loading microparticle can achieve different types of drug loading and different release speeds, can be directly implanted into tissues, and have the technical advantages of both microspheres and radioactive particles.

An example particle therapy system includes a toroid-shaped gantry having a central axis. The toroid-shaped gantry has a cover. The cover includes one or more segments that are rotatable at least partly around the central axis of the toroid-shaped gantry to create an unobstructed opening in the toroid-shaped gantry. The particle therapy system includes a patient couch configured to move relative to a hole in the toroid-shaped gantry, an imaging system coupled to an interior of the toroid-shaped gantry and configured for rotation about the hole in the toroid-shaped gantry, where the imaging system is configured to capture images of a patient on the patient couch, and a nozzle coupled to the interior of the toroid-shaped gantry and configured for rotation about the hole in the toroid-shaped gantry. The nozzle is configured to deliver radiation to a target in the patient based on one or more of the images.